Clinical Trial Update: Role of ARMA in Selective Subset of Refractory GERD Patients. [NA]

View source ↗

Summary

This clinical trial evaluated the role of ARMA in a selective subset of patients with refractory gastroesophageal reflux disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Reflux Esophagitis

Drugs mentioned

• ARMA

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: GERD, Reflux | NA | Status: COMPLETED